Cargando…

A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still’s Disease With Tocilizumab

Macrophage activation syndrome (MAS) is a fatal complication of adult-onset Still’s disease (AOSD). Although anti-cytokine agents have been recommended for refractory AOSD or complicated with MAS, MAS cases have been rarely reported during anti-cytokine treatment. Herein, we describe the first AOSD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ju Ho, Ha, You-Jung, Kang, Eun Ha, Chang, Sung Hae, Lee, Yun Jong, sup, 3
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327616/
https://www.ncbi.nlm.nih.gov/pubmed/37475901
http://dx.doi.org/10.4078/jrd.2022.29.2.123

Ejemplares similares